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Background: Reliable in vitro toxicity testing is needed prior to the commencement of in vivo testing necessary
for hazard identification and risk assessment of nanoparticles. In this study, the cytotoxicity and uptake of 14 nm
and 20 nm citrate stabilised gold nanoparticles (AuNPs) in the bronchial epithelial cell line BEAS-2B, the Chinese
hamster ovary cell line CHO, and the human embryonic kidney cell line HEK 293 were investigated.
Methods: Cytotoxicity of the AuNPs was assessed via traditional XTT-, LDH-, and ATP-based assays, followed by
cell impedance studies. Dark-field imaging and hyperspectral imaging were used to confirm the uptake of AuNPs
into the cells.
Results: Interference of the AuNPs with the XTT- and ATP-based assays was overcome through the use of cell
impedance technology. AuNPs were shown to be relatively non-toxic using this methodology; nevertheless CHO
cells were the most sensitive cell type with 20 nm AuNPs having the highest toxicity. Uptake of both 14 nm
and 20 nm AuNPs was observed in all cell lines in a time- and cell type-dependent manner.
Conclusions: Using the cell impedance and dark-field hyperspectral imaging technologies, it was possible to study
the toxicity of AuNPs in different cell lines and show that these cells could internalize AuNPs with their subsequent
intracellular aggregation. It was also possible to show that this toxicity would not correlate with the level of uptake
but it would correlate with cell-type and the size of the AuNPs. Therefore, these two label-free methodologies used
in this study are suitable for in vitro studies on the effects of AuNPs, and could present themselves as appropriate
and valuable methodologies for future nanoparticle toxicity and uptake studies.
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As the field of nanotechnology develops, studies to investi-
gate the toxicity of engineered nanoparticles become
critically important. A tiered approach for nanoparticle
toxicity tests has been proposed [1] whereby in-depth
physicochemical characterisation of engineered nanoma-
terials is performed followed by a tier of in vitro testing.
Positive, consistent results from in vitro studies lead to a
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reproduction in any medium, provided the oridentification and classification. Therefore, it is imperative
that the in vitro toxicity assessment provides reliable
data before the commencement of time-consuming and
expensive in vivo studies.
The traditional cytotoxicity assays that are frequently
used to assess in vitro toxicity of AuNPs include the
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay which is based on the reduction of the
tetrazolium salt by the mitochondria to form a colorimetric
product, the release of lactate dehydrogenase (LDH), a
marker of membrane integrity, and also intracellular
adenosine triphosphate (ATP) levels, a marker of metabol-
ically active cells. A previous study which investigated
the size-dependent cytotoxicity of 0.8 nm, 1.2 nm, 1.4 nm,Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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J774A1, and SK-Mel-28 found that nanoparticles in the
0.8 – 1.8 nm range were highly toxic whilst the 15 nm
nanoparticle was shown to be relatively nontoxic with the
MTT colorimetric assay [2]. AuNPs of 20 nm and 100 nm
did not affect the viability of human retina microvascular
endothelial cells as determined by the MTT assay in vitro
[3], in addition no toxicity of the 20 nm AuNPs in the rat
astrocyte cell line CTX-TNA2 or in human retinoblast-
oma cells SNUOT-Rb1 was shown. Further cytotoxicity
studies with the MTT assay have shown no effect on
the viability of the cells exposed to citrate stabilized
AuNPs of sizes 3 nm, 5 nm, 12 nm, 17 nm, 37 nm, 50 nm,
and 100 nm in HeLa cells [4], no effect of 20 nm AuNPs
on the viability of human dermal fibroblasts-fetal cells [5]
and no effect of 9.5 nm, 11.19 nm, and 25 nm citrate
stabilised AuNPs on A549 and NCIH441 cells with the
exception of the 11.19 nm and 25 nm at the highest
concentration in A549 cells which displayed mild toxicity
[6]. Yet, in this latter study, a dose- and time-dependant
increase of LDH release was observed [6]. Using 3-(4,5-
dimethylthiazole-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazoliumin (MTS), a tetrazolium salt
similar to MTT, no toxicity was observed in human
cerebral microvascular endothelial (hcMEC/D3) cells
and human dermal microvascular endothelial (HDMEC)
cells incubated with 10 nm, 11 nm, and 25 nm AuNPs,
however, once again, a dose-dependent release of LDH
was seen following incubation with the nanoparticles
[7]. A more recent study demonstrated that 21 nm
citrate-stabilised AuNPs were toxic to PC-3 and MCF-7
cells in a time- and dose dependent manner based on
both MTT and LDH release [8]. Finally, the 17 nm citrate
capped AuNPs had shown toxicity to A549 cells assessed
by both MTT and LDH assays as well as by the ATP
depletion measurements [9].
Despite differences in the size of the AuNPs used as
well as the cell types implemented, results presented in
the literature may not allow one to draw meaningful
conclusions as to the toxicity or lack thereof for citrate-
capped AuNPs when assessed by the MTT, LDH, and
ATP tests. An important aspect about these toxicity test
systems is that they rely on absorbance, fluorescence
or luminescence changes of the final product. As AuNPs
absorb light in the visible region (~520 nm), their inter-
ference with these colorimetric, flourometric, and lumi-
nometric test systems have been shown to be of great
concern [10-12]. In addition to toxicity, it is also necessary
to investigate the uptake of nanoparticles (NPs) as their
intracellular fate could influence cell toxicity and cellular
functioning. Using Transmission Electron Microscopy
(TEM), it was shown that the incubation of AuNPs of
diameters of 14, 30, 50, 74, and 100 nm with the mamma-
lian cell line HeLa could produce the cellular uptake of allsizes of AuNPs, but the maximum uptake was attained
with the 50 nm AuNPs [13]. With confocal microscopy,
an increased accumulation within U937 cells was shown
for both 20 nm and 30 nm AuNPs as compared to the 45
nm AuNP counterparts [14]. Implementing both Scanning
Electron Microscopy (SEM) and TEM, cellular uptake
and intracellular distribution of 13 and 45 nm AuNPs
in CF-31 cells could be observed and NPs were found
to be located in intracellular vacuoles. The number of
particles per vacuole was however greater for the 13
nm AuNPs, even though the vacuole number per cell
for both sizes of AuNPs was similar [15]. Lastly, TEM
was used to show the uptake of 15 nm AuNPs by triple
cell co-culture which consisted of human blood monocyte
derived macrophages and dendritic cells as well as the
A549 human alveolar epithelial cells [16].
In addition, AuNP toxicity in relation to cellular uptake
has been studied. For example, it was found that 18 nm
citrate-capped AuNPs were not toxic at ~ 100 μM to
K562 cells assayed by MTT despite their increased cellular
uptake which was assessed by TEM [17]. On the other
hand, 10 nm and 25 nm citrate capped AuNPs were
found to be toxic to HDMEC and hcMEC/D3 cells when
assessed by the MTS test but were not toxic with the LDH
test despite their increased intracellular concentration
when assessed with TEM and with inductively coupled
plasma and atomic emission spectroscopy (ICP-AES) [7].
In this study, we demonstrate the use of two label-free
technologies to investigate the cytotoxicity and uptake of
14 nm and 20 nm citrate stabilized AuNPs in three cell
lines. Through the use of cell impedance technology,
potential interference of the nanoparticles with the toxicity
test can be eliminated; whilst the use of dark-field imaging
and hyperspectral imaging can confirm the presence of
nanoparticles within the cells studied.
Results
Characterisation
Table 1 shows the physicochemical properties of the
AuNPs in milli-Q H2O. The surface charge of the particles,
as described by their zeta (ζ) potential, are all negatively
charged and of similar value. Table 2 shows the physi-
cochemical properties of the AuNPs after centrifugation
and resuspension in both RPMI and Ham’s-F12 culture
medium. The pH of the RPMI and Ham’s-F12 culture
medium at 37°C are pH 7.66 and 7.96 respectively. In all
instances, the pH of the culture medium decreased slightly
when the particles were resuspended therein; however the
observed decreases were not biologically significant. The
particles dispersed in Ham’s F12 culture medium showed
a broader peak as compared to those in RPMI culture
medium and water (Table 2 and Figure 1), owing to the
difference in the refractive index of the medium and
the final composition. AuNPs were further characterised
Table 1 Physicochemical properties of gold nanoparticles in milli-Q water
Nanoparticle Particle size determined by TEM ζ-potential Citrate concentration UV–vis Particles/ml (at 1 nM)
14 nm AuNP 14 ± 2 nm −33.5 mV 0.025% 520 nm 2.25 x 1012 nps/ml
20 nm AuNP 20 ± 2 nm −37.9 mV 0.023% 524 nm 7.76 x 1011 nps/ml
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Figure 2. The TEM data demonstrates that the integrity
of the AuNPs suspended in cell culture medium was
maintained as compared to the AuNPs in water, with
minimal signs of particle aggregation present. The AuNPs
were primarily spherical in shape, with some ellipsoid
nanoparticles present, probably due to synthetic condi-
tions employed as factors such as salt concentration,
pH, and temperature during synthesis have been shown
to affect the polydispersity of AuNPs [18,19].Toxicity studies
XTT, LDH, and ATP assays
Figure 3A shows the toxicity of the 14 nm AuNPs in
BEAS-2B cells based on the XTT (2,3-bis-(2-methoxy-4-
nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide) assay.
In the figure the hydrogen peroxide positive control showed
a decrease in absorbance, indicative of a decrease in
cell viability. Based on the XTT assay, it can be deduced
that at 1 nM the AuNPs exhibit only mild toxicity,
however at 5 nM there is an increase in viability as
compared to the untreated control cells. Figure 3B shows
the cytotoxicity of the 14 nm AuNPs as determined by
the CytoTox-ONE™ assay. The principle of this assay is
the measurement of the release of LDH through the
measurement of the fluorescence of the final assay product,
resorufin. Cytotoxicity was calculated in accordance to
the manufacturer’s instructions and is expressed as a
percentage of maximum LDH release. From this assay
data, the AuNPs are considered non-toxic to the cells
under the same conditions as the XTT experiment.
Figure 3C shows the toxicity of 14 nm AuNPs assessed
by the CellTiter-Glo® Luminescent Cell Viability Assay
which indicates the amount of ATP present. Cells were
lysed to release ATP, followed by a luciferase reaction to
produce a stable luminescent signal proportional to the
ATP present. In this assay system, the manufacturer’s
guidance manual states that cell washing and the removal
of culture medium is not required. From the resultsTable 2 Physicochemical properties of gold nanoparticles sus
Nanoparticle ζ- Potential (mV) pH at 37°C
RPMI Ham’s-F12 RPMI (pH 7.66) Ham’s-F12 (p
14 nm AuNP −10.24 −11.40 7.61 7.84
20 nm AuNP −12.06 −11.30 7.61 7.87presented in this figure, it can be concluded that AuNPs
were toxic in a concentration dependent manner.
Contradictory cytotoxicity results obtained between the
XTT-, LDH-, and ATP-based assays suggests possible
interference of tested AuNPs with these three assay
systems. Indeed, such interference could be confirmed by
the concentration-dependent increase in the absorbance
by AuNPs at a wavelength of 450 nm in the absence of
cells but in the presence of unreduced XTT (Figure 3D).
Subsequently, the absorbance of particle-containing medium
controls, as seen in Figure 3D, was subtracted from
the XTT viability data, shown in Figure 3A. From this
amended data (Figure 3E), a conclusion can be made
that dose-dependent toxicity is produced relative to
the untreated cells.
However, no meaningful interference on fluorescence or
luminescence measurements were observed when parti-
cles alone, resuspended in medium, were included in the
LDH and ATP assays (results not shown). However, when
a further experiment was conducted to investigate the
effects of the AuNPs on the reaction that occurs during
the ATP-based assay, namely the conversion of luciferin
substrate to luminescent oxyluciferin in the presence of
ATP, it can be seen that with an increase in AuNP con-
centration, a decrease in luminescent signal is observed
(Figure 3F), suggesting that the AuNPs are interfering with
the conversion of luciferin to oxyluciferin at high con-
centrations. If a comparison of results is made between
Figure 3C and 3F, it is possible that the observed decrease
in viability at 5 nM AuNPs in Figure 3C could be caused
by interference of the AuNP with the assay reaction.
The accepted norm for the application of these assay
systems is the inclusion of medium controls in the experi-
mental setup with no attention to the optical properties
of the particles themselves or the particles’ interactions
with the assay reagents. It can therefore be concluded
that such interference by AuNPs with detection of the
assay end-product by absorbance cannot be ignored for
the XTT assay system. However, within the ATP assay, the
AuNPs do not produce a luminescent signal themselves,pended at 1 nM in culture medium
Absorbance peak Average particle size in nm
determined by TEM (Std Dev)
H 7.96) RPMI Ham-F12 RPMI Ham-F12
557 nm 535 nm 17 nm (± 3 nm) 16 nm (± 3 nm)
557 nm 532 nm 22 nm (± 4 nm) 24 nm (± 3 nm)
Figure 1 Absorbance spectrum of the gold nanoparticles. The UV–vis spectrum of 14 nm and 20 nm AuNPs at 1 nM in A) milli-Q water, B) in
RPMI culture medium, and C) in Ham’s F12 culture medium.
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a luminescent product.
Dynamic monitoring of cytotoxic response using RTCA
cell impedance system
Contradictory results with the XTT, LDH and ATP assay
systems and the subsequent illustration that AuNPs inter-
fere in the absorbance readings of the XTT assay as well
as the ATP assay, has necessitated the use of an alternate
system that does not rely on optical detection of the finalproducts. Impedance technology such as the xCELLigence
Real-TimeCell Analyzer (RTCA) system assesses the cell
index and therefore eliminates problems with interference
of the AuNPs with determination of cell viability. The
normalised cell index is indicative of the level of adhesion
and therefore associated with the viability of the cells.
AuNPs alone in culture medium showed no effect on
cell index whereas treating BEAS-2B cells with 500 μM
hydrogen peroxide used as a positive control for cell
death caused a decrease in cell index (See Additional
A B C
D E F
Figure 2 Characterisation of the gold nanoparticles in milli-Q water and in culture medium using Transmission Electron Microscopy.
TEM images of 14 nm AuNPs in (A) water, (B) RPMI culture medium, and (C) Ham’s F12 culture medium; and 20 nm AuNPs in (D) water, (E) RPMI
culture medium, and (F) Ham’s F-12 culture medium.
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index over time of the BEAS-2B (Figure 4A and B), HEK
293 (Figure 4C and D), and the CHO cells (Figure 4E and
F) when treated with the 14 nm and 20 nm AuNPs. In all
cases, cells were treated for 24 hours after seeding and
the cell index was normalised at the point of treatment.
Each cell line had its own unique growth curve and
treatment was carried out whilst the cells were in the
early stages of log growth phase. The slope of the curves, a
term describing the changing rate of the CI within a given
time period, was calculated between the point of treat-
ment and point of confluence, and any significant dif-
ferences between the untreated and treated slopes are
indicated in figure legend. The cells treated with 14 nm
AuNPs showed significant differences from the untreated
controls within the BEAS-2B and the HEK 293 experi-
ments (Figure 4A and C). In both instances, the treated
cells showed a similar growth trend as the untreated cells
and no dose-dependent response was observed. However,
both the 14 nm and 20 nm AuNPs showed significant
differences and an apparent dose–response to the CHO
cells (Figure 4E and F), and the 20 nm AuNPs showed
greater toxicity based on the greatest decrease of CI.Intracellular uptake using hyperspectral imaging microscopy
The CytoViva Hyperspectral Imaging (HSI) System
provided dark-field images of the cells following their
incubation with AuNPs and fixation. To observe the
internalisation of the particles, it was possible to focus
the microscope on various focal planes throughout the
fixed cells. Figure 5 shows a single BEAS-2B cell that
has been incubated with 14 nm AuNPs at 1 nM for an
hour. The image illustrates 4 focal planes within the cell.
In (A) the particles are out of focus, but as the focus of
the microscope moves through (B) to (D), one is able
to observe various particles within the outline of the
cell which come into and then go out of focus, thereby
confirming that the AuNPs have been internalised. This
approach has been used to confirm internalisation of TiO2
NPs in fibroblasts [20], and silver NPs in nematodes [21].
Figure 6 confirms the uptake of the AuNPs in BEAS-2B
cells. The 14 nm (Figure 6A) and 20 nm (Figure 6B)
showed high levels of uptake, even after an hour of
incubation. The particles seemed to accumulate and form
aggregates within the cells. Figure 7 demonstrates the
uptake of the AuNPs into HEK 293 cells. The cells
treated with 14 nm AuNPs (Figure 7A) had cellular
Figure 3 Toxicity studies using conventional assays: XTT, LDH, and ATP assays. (A) BEAS-2B cells were treated with either 1 nM or 5 nM of
14 nm AuNPs for 1 hour prior to toxicity testing using the In Vitro Toxicology Assay Kit (XTT assay). Absorbance measured at 450 nm and a
reference wavelength of 600 nm. (B) BEAS-2B cells were treated with either 1 nM or 5 nM of 14 nm AuNPs for 1 hour prior to toxicity testing
using the CytoTox-ONE™ assay (LDH assay). Lysis solution was used as a positive control for maximum LDH release and sample LDH is expressed
as a percentage of this maximum release. Fluorescence measured at 560 nm excitation, 590 nm emission. (C) BEAS-2B cells were treated with
either 1 nM or 5 nM of 14 nm AuNPs for 1 hour prior to toxicity testing using the CellTiter Glo assay (ATP assay). Luminescent signal was
measured and viability is expressed as a percentage of the untreated control cells. (D) The absorbance of 1 nM and 5 nM AuNPs in culture
medium and with unreduced XTT at 450 nm. (E) Absorbance values obtained when data from (D) was subtracted from (A). (F) Luciferin
substrate from the CellTiter Glo assay was incubated with ATP and 14 nm AuNPs to produce the luminescent product oxyluciferin prior to
measurement of the luminescent signal.
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AuNPs (Figure 7B) had minimal cellular uptake. There
was some accumulation of all nanoparticles in the cells
after 6 hours, although this uptake was not as high as
in BEAS-2B cells. Figure 8 presents the uptake of the
14 nm and 20 nm AuNPs in CHO cells. Minimal AuNP
uptake was observed in the CHO cells after an hour,
however an increase and high accumulation of the
nanoparticles was observed for the 14 nm (Figure 8A)
and 20 nm (Figure 8B) AuNPs after 4 and 6 hours with
the 20 nm AuNPs cellular uptake being higher than
that of the 14 nm AuNPs.
Figure 9 represents the spectral profiles of 14 nm and
20 nm AuNPs. Nanoparticle solution was spread on a
slide and allowed to dry prior to HSI. Ten randomly
selected spectra were obtained from nanoparticles that
appeared to be either singularly dispersed (A and C) orhad formed larger aggregates (B and D) on the slide.
Each coloured line represents the spectrum from a single
pixel, and these collections of representative spectra form
a known spectral library of the nanoparticles. In these
figures, it can be seen that individually dispersed AuNPs
of the two sizes tend to have homogenous curves within
the sample, as represented in Figure 9A and C for 14 nm
and 20 nm nanoparticles, respectively. The AuNPs at
both sizes tend to have a predominant single peak at
approximately 670 nm. Figure 9B and D illustrate a
range of spectra for aggregated 14 nm and 20 nm AuNPs,
respectively. The non-uniformity of these spectra may
probably be due to the different sizes of the agglomerates
in the sample. In addition, the spectral profiles of the
aggregated AuNPs tend to have broader peaks than
their singularly dispersed counterparts as well as the
appearance of a second peak at approximately 800 nm.
Figure 4 Normalised cell index of cells treated with AuNPs. BEAS-2B cells (A and B), HEK 293 cells (C and D), and CHO cells (E and F) were
treated with 14 nm AuNPs (left panel) and 20 nm AuNPs (right panel). BEAS-2B, HEK 293, and CHO cells were seeded and allowed to recover for
24 hours prior to treatment for 72 hours, 36 hours, or 42 hours, respectively. The slope of the curves was calculated and t-test conducted to
determine differences between treated and untreated control cells. In (A) and (C), all treatments were statistically different from untreated control
(p < 0.05) whilst no significant differences were observed in (B) and (D). In (E), 2 nM (p < 0.05) and 5 nM (p < 0.01) were statistically different
from untreated control; whilst in (F) both 2 nM and 5nM treatments were statistically different from the untreated control at p < 0.01; n ≥ 3.
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Component Analysis (PCA) was performed on these
spectra to identify the principal components (PCs) that
are responsible for the spectral variation between the
different sized nanoparticles, the score plot obtained
could not discriminate between the different sizes (See
Additional file 1: Figure S2). Subsequently, these spectra
may be used to confirm the presence of gold nanoparticles
but may not be used to discriminate between particle
sizes.Spectral Angle Mapper (SAM) is a process for the
identification of a known material in an image acquired
using hyperspectral imaging. The process is performed by
comparing the known spectra for a material to unknown
spectra and identifying pixels in the unknown image that
map the known spectra, irrespective of the light intensity.
Using this process on scans of the cells incubated with the
AuNPs, a representative output was obtained (Figure 10).
In this figure the HSI scan of BEAS-2B cells incubated with
1 nM 14 nm AuNPs for 4 hours represents an “unknown”
A B
C D
Figure 5 Dark-field image at 100x magnification of BEAS-2B cells incubated with 14 nm AuNPs for 1 hr. Cells were washed, fixed, and
immobilised onto slides prior to image capture using the CytoViva system. Four focal planes, (A) through to (D), are observed as the focus of the
microscope moves through the cell.
(A) 1 hr
(B) 1 hr
(A) 4 hr (A) 6 hr
(B) 4 hr (B) 6 hr
Figure 6 Dark-field images of BEAS-2B cells incubated with AuNPs. Dark-field images were captured at 60x magnification of BEAS-2B cells
incubated with either (A) 14 nm or (B) 20 nm AuNPs for 1 hr, 4 hrs, or 6 hrs.
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Figure 7 Dark-field images of HEK 293 cells incubated with AuNPs. Dark-field images were captured at 60x magnification of HEK 293 cells
incubated with either (A) 14 nm or (B) 20 nm AuNPs for 1 hr, 4 hrs, or 6 hrs.
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of the singularly dispersed 14 nm AuNPs was mapped
against this image (Figure 10B), and the spectral library of
aggregated 14 nm AuNPs was also mapped (Figure 10C).
Both the aggregated and singularly dispersed spectral(A) 1 hr (A) 4 hr
(B) 1 hr (B) 4 hr
Figure 8 Dark-field images of CHO cells incubated with AuNPs. Dark-f
with either (A) 14 nm or (B) 20 nm AuNPs for 1 hr, 4 hrs, or 6 hrs.libraries mapped onto the images of the cells, thereby
verifying the presence of gold nanoparticles in the cells.
However it can be seen that the aggregated AuNPs
matched more pixels within the cells than the singularly
dispersed AuNPs indicating that there is a better match(A) 6 hr
(B) 6 hr





Figure 9 Spectral profiles of 14 nm and 20 nm AuNPs. Ten spectral profiles of randomly selected AuNPs that appeared visually to be either
(A and C) in single suspension, or (B and D) aggregated nanoparticles. Each coloured line represents the spectrum from a single pixel.
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dispersed spectral library. Therefore, the presence of
aggregated rather than singularly dispersed gold nano-
particles could be assumed. This latter observation made
when using SAM concurs with visual observations made
from the spectral profiles of AuNPs in the absence of cells
(Figure 9) and those from inside the cells (See Additional
file 1: Figure S3 and S4).
Discussion
Many commercially available toxicity kits rely on the
optical properties of the reaction product as the basis ofA B
Figure 10 Representative images of the SAM analyses. (A) HSI scan of
image indicating pixels of (A) that matched the spectral library of 14 nm si
(A) that matched the spectral library of the 14 nm aggregated nanoparticlethe detection assay. However, AuNPs absorb light in the
visible region and also are able to potentially adsorb
molecules such as indicator dyes [22]. Interference would
therefore be expected when using the XTT assay.
Although the assay-data presented with XTT on the
toxicity of AuNPs agree with those presented earlier by
other investigators using MTT [7], the lack of toxicity
of these nanoparticles using LDH is in contrast with
those presented by these same authors. This could be
due to the fact that kits used by these authors were
absorbance based, where the absorbance of the final
product was measured at 490 nm; whereas in the studyC
BEAS-2B cells treated with 1 nM 14 nm AuNPs for 4 hours; (B) SAM
ngularly dispersed nanoparticles; (C) SAM image indicating pixels of
s.
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was fluorescence-based. Interference was also observed
with the ATP bioluminescence assay system; however
this was not due to the optical properties of the AuNPs,
but rather interference with the production of the
measured end-product. It is therefore possible that the
contradictory data on the toxicity of AuNPs may be as
a result of interference of these AuNPs with the toxicity
assay substrate and also their subsequent assay products.
Similar observations have been reported on the inter-
ference of nanoparticles other than AuNPs when using
toxicity test systems such as MTT (similar to XTT),
2′,7′-Dichlorofluorescein (DCF), and IL-8 ELISA assays
[23]. In an earlier review, while discussing different
in vitro methodologies used for nanoparticle toxicity
assessment, these authors have summarized nanoparticle
characteristics such as high adsorption capacity, surface
charge, and catalytic activity as potential causes of the
interference of nanoparticles with these toxicity assays
[24]. Kroll et al., [23] suggested an approach to prevent
interference of nanoparticles with in vitro toxicity assays
that involves altering assay protocols or lowering particle
concentrations. However, the authors did observe that
interference was assay- and particle-specific, and recom-
mended that each in vitro methodology be evaluated
for each individual nanoparticle. Although effective, this
validation is time-consuming and possibly expensive,
especially if the results of the validation show that the
interference by nanoparticles cannot be overcome. We
therefore suggest the use of cell impedance to ascertain
the cytotoxicity of nanoparticles especially with those that
have plasmon effects such as gold and silver nanoparticles.
The xCELLigence RTCA technology measures imped-
ance changes caused by the gradual increase of electrode
surface occupation by cells represented as a Cell Index
(CI) which reflects the state of the ionic environment
at the electrode/solution interface. This impedance is
influenced by the presence of cells cultured on plates
on top of these electrodes, and therefore CI values
were used to monitor cell viability where cell adhesion
was considered as the cell viability end-point [25,26].
Cell-based label-free technologies such as the xCELLigence
RTCA system have been implemented as part of the
preclinical drug development process [27-29] and also
for the evaluation of the cytotoxicity of a variety of
dissolved chemicals [30-33]. This technology was also
used to assess the cytotoxicity of a variety of nano-
particles including quartz [34], cobalt ferrite [35], gold
nanoparticles [36], quantum dots and gold nanorods
[37], ZnO, CuO, and TiO2 [38] and other inorganic
nanoparticles [39].
Using this impedance technology, it was possible to
assess the toxicity of 14 nm and 20 nm AuNPs on three
different cell lines. It was found that the decrease ofcell index was slight for both 14 nm and 20 nm AuNPs,
but only significant for the 14 nm AuNPs, indicating
minimal toxicity to the BEAS-2B cells (Figure 4A and
B). Similar findings were obtained with the HEK 293
cells (Figure 4C and D). The most sensitive cells to the
AuNPs were the CHO cells with 20 nm AuNPs having
the highest toxicity (Figure 4E and F).
It is important to note that our results, generated with
the RTCA technology, on the toxicity of 14 nm AuNPs
did not correlate well with those generated with the
conventionally used XTT- or ATP-based toxicity assays.
Positive correlation was however reported in the literature.
For example, a correlation was found in the toxicity of
drugs when assessed by either neutral red uptake assay or
the RTCA [29], or in the cytotoxicity of sodium arsenite,
cadmium chloride and cis-platinum assessed by MTT and
RTCA [33], or in the immunocytotoxicity of baboon sera
on pig cells with the MTT and RTCA [40] or cell toxicity
assay using the Sulforhodamine B for staining proteins
and measuring absorbance at a wavelength of 565 nm in
correlation to RTCA [41]. Such correlation was even
observed between impedance-based technology and the
MTS assay for the assessment of CTAB-capped gold
nanoparticles of difference shapes [36,37]. The difference
between those reported in the literature and those
observed in the present experiments is that we have
found that the materials tested have shown absorbance or
luminescence (Figure 3) and therefore have interfered
in the assessment of the final products produced from
these test systems and subsequently no such correlation
could be observed between our data generated by the
conventional assay systems and that of the RTCA.
Although the lack of correlation observed between the
XTT assay system and those generated with impedance
technology may be in contrast to those reported earlier
with the MTS assay system [36,37], the explanation
would be that the interference caused in these assays
results in apparent increased toxicity, irrespective of
actual toxicity, whilst the impedance technology presents
a more accurate representation of whether something
is toxic or non-toxic.
In the present study, CytoViva’s hyperspectral imaging
technology was used to assess intracellular uptake by three
different cell lines of two sizes of AuNPs; namely 14
and 20 nm. This technology was previously implemented
to determine the potential distribution of multi-walled
carbon nanotubes (MWCNT) in different regions and
target cells in the lung [42], for the assessment of a
panel of metal nanoparticle catalysts for their antifungal
activities against Candida albicans [43], and for the
assessment of internalization of silver nanoparticles and
subsequent cellular changes in U937 cells in relation
to toxicity [44]. Via the hyperspectral imaging tech-
nology, we were able to assess intracellular uptake of
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high levels and with minimal toxicity detected, with
the observation that these particles were aggregated
once internalized by these cells. Similarly, the uptake
of these two different sizes of AuNPs by the HEK 293
cells was time dependent and the 20 nm AuNPs did
not produce a toxic response. Finally, the uptake of
AuNPs by the CHO cells was size dependent where
the 14 nm and the 20 nm AuNPs could enter cells in
a time-dependent manner with higher toxicity found
with the 20 nm AuNPs. Differences in uptake by
HeLa, A549, and 1321N1 cell lines have previously
been shown for 40 nm and 200 nm polystyrene
nanoparticles [45].
As both AuNPs tested were negatively charged, any
differences in uptake within a cell system are probably
due to size differences. Resuspension of AuNPs in RPMI
or Ham’s-F12 medium did increase the ζ-potential and
subsequently may have increased the tendency for the
nanoparticles to aggregate. This was confirmed with the
differences in the hydrodynamic size of the nanoparticles
measured in the different cell culture media using DLS
(see Additional file 1: Table S1 and Figure S5). It is also
worthwhile mentioning that the individual composition
of the different cell culture media could affect protein
corona formation, which, in turn, would also affect up-
take and possibly the toxicity of the nanoparticles [46].
It was possible to show, with CytoViva measurements,
that aggregation of the nanoparticles occurred after the
uptake by the three different cell types. This aggregation
could be visually observed due to the high signal-to-noise
dark-field images, and confirmed through SAM analyses.
As for the mechanism of internalization of the negatively
charged AuNPs within the three different cell types, it has
been previously postulated that uptake of negatively
charged AuNPs may be mediated through nonspecific ad-
sorption of serum proteins onto the gold surface which
may aid nanoparticle entry via the mechanism of receptor
mediated endocytosis [13]. Further studies will therefore
be conducted to elucidate mechanisms of AuNP uptake,
within various cell lines, using the CytoViva system.
This study demonstrates the use of two label-free
technologies, namely cell impedance and hyperspectral
imaging, as desirable systems for use in the assessment
of toxicity and uptake of AuNPs in adherent cell lines.
These systems have assisted us in circumventing the
contradictory results observed with the use of the trad-
itional XTT, LDH and ATP assays for the cytotoxicity
of AuNPs.
Conclusions
The two methodologies presented herein have shown
to be effective in the analysis of cytotoxicity and uptake
of AuNPs. An advantage of these techniques is that bothare label-free and thereby eliminate potential interference
with detection. Interference was overcome with the use of
cell impedance to measure cytotoxicity; and the CytoViva
system provided dark field images of AuNP internalisation




Tetrachloroaurate (HAuCl4.3H2O) and trisodium citrate
(Na3C6H5O7.2H2O) were purchased from Sigma Aldrich
and used without further purification. The 14 nm and
20 nm AuNPs were prepared with sodium citrate as the
reducing agent according to literature methods [47,48].
In brief, the 14 nm gold nanoparticles were prepared by
adding trisodium citrate aqueous solution (10 mL, 17 mM)
into 180 mL (0.3 mM) of boiling HAuCl4.3H2O aqueous
solution. The mixture was boiled under reflux for 15
minutes and the resultant suspension allowed to cool
to room temperature. The deep red citrate-capped gold
nanoparticle suspension was further stirred overnight
followed by filtration using 0.25 μm syringe sterile filter
before use. The 20 nm gold nanoparticles were prepared
in a similar way, but with 8.8 mL of tri-sodium citrate
added into 180 mL of 0.3 mM HAuCl4.3H2O aqueous
solution. The synthesis was performed under sterile
conditions.
The physicochemical properties of the synthesized
citrate-capped gold nanoparticle
The physicochemical properties of the AuNPs in milli-Q
water and in two cell culture medium were determined.
For the stability of AuNPs in culture medium, the
nanoparticles suspended in milli-Q H2O, were centrifuged
at 13 000 x g for 30 min and re-suspended in RPMI
culture medium or Ham’s culture medium and further
characterized. The absorbance spectrum of the AuNPs
was determined on the Thermo Scientific Multiskan GO
spectrophotometer. Zeta potential (ζ-potential) measure-
ments were performed using Malvern Instruments’
Zetasizer Nano ZS while pH measurements were per-
formed at 37°C using the CyberScan pH 6500 instrument.
TEM, operating at 120 kV using JOEL-JEM 1010, was
used for size measurement experiments where colloidal
samples were deposited, as droplets, on the carbon coated
copper grids and allowed to dry prior to analysis. A mini-
mum of 50 nanoparticles were measured using ImageJ
1.46r (National Institutes of Health, USA) to obtain an
average particle size.
Cell cultures
Three cell lines were used in this study, namely the
bronchial epithelial cell line BEAS-2B, the Chinese
hamster ovary CHO cell line, and the human embryonic
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cultured under standard culturing conditions (37°C, 5%
CO2 in a humidified environment). BEAS-2B cells and
HEK 293 cells were cultured in RPMI-1640 medium with
L-glutamine, 10% heat-inactivated foetal bovine serum
(FBS) and 1% Penicillin/Streptomycin, hereafter referred
to as RPMI culture medium. CHO cells were cultured
in Ham’s-F12 with L-glutamine, 10% heat-inactivated FBS
and 1% Penicillin/Streptomycin, hereafter referred to as
Ham’s F12 culture medium. After reaching sub-confluency,
the monolayer was washed with phosphate buffered saline
(PBS) and harvested by a brief incubation with a trypsin/
EDTA solution. The cells were resuspended in growth
medium and viability determined by the trypan blue
cell viability assay. Cell culture reagents were purchased
from Lonza, Belgium.
Toxicity
Assessment of cytotoxicity using conventional assays
BEAS-2B cells were seeded at 1 × 104 cells/well in a 96-
well plate and allowed to proliferate for 24 hours before
AuNP treatment. RPMI culture medium without phenol
red was used. Untreated control wells contained medium
as described. Cells were treated with 1 or 5 nM of 14 nm
gold nanoparticles for an hour. Cell viability was then
assessed using both the In Vitro Toxicology Assay Kit,
XTT based (Sigma-Aldrich), the CytoTox-ONE™ Homo-
geneous Membrane Integrity Assay (Promega), and the
ATP CellTiter Glo assay (Promega).
a. XTT assay: Positive control wells received 500 μM
hydrogen peroxide (Merck). XTT was reconstituted
with 1% PMS and as per the manufacturer’s
instructions, and added to each well to a final
volume of 20% per well. The plate was incubated
for 2 hours and the absorbance of which is read at
450 nm. To test for interference of the AuNPs with
the optical readout, the absorbance of 1 nM and 5
nM AuNPs in culture medium with unreduced XTT
was measured.
b. CytoTox-ONE™ assay: This assay is based on the
measurement of the release of lactate dehydrogenase
(LDH). Lysis solution provided with the kit was used
to generate maximum LDH Release. The CytoTox-
ONE™ Reagent was added to each well in a 1:1 ratio.
The plate was incubated at 22°C for 10 mins. Stop
solution was added and the plate was shaken for
10 secs. LDH released into the culture medium is
measured with a 10-minute coupled enzymatic assay
that results in the conversion of resazurin into
resorufin. Fluorescence of resorufin was then
measured at 560 nm excitation, 590 nm emission.
c. The CellTiter-Glo® Luminescent Cell Viability Assay:
This is based on the quantitation of ATP, whichsignals the presence of metabolically active cells. The
CellTiter-Glo® Reagent was added directly to cells in
multiwell plates. The plate was incubated at room
temperature for 10 minutes, to lyse the cells, for the
release of the ATP. Luciferin is catalyzed by luciferase
in the presence of Mg2+, ATP and molecular oxygen
to generate a stable luminescent signal. To test for
interference of AuNPs with the conversion of
substrate to product, the CellTiter-Glo® Reagent was
incubated with 1.5 μM ATP as a
co-factor and AuNPs.
Assessment of cytotoxicity using cell impedance
Cytotoxicity studies were conducted using the xCELLigence
RTCA single plate (SP) instrument from ACEA Biosciences
with RTCA software (version 1.2). Cell Index (CI) is a
measure of the electrode impedance which reflects the
state of the ionic environment at the electrode/solution
interface. This impedance is influenced by the presence of
cells cultured on plates on top of these electrodes, and
therefore the CI values are used to monitor cell viability.
BEAS-2B, HEK 293, and CHO cells were seeded at 1 ×
104 cells/well, 5 × 104 cells/well, and 3 × 103 cells/well
respectively in a 96-well E-Plate. Cells were placed in the
RTCA station and allowed to proliferate for 24 hours for
all cells prior to treatment, during which time a scan
was acquired every 15 minutes. The cells were then treated
with the 14 nm or 20 nm AuNPs at final concentrations of
1 nM, 2 nM, and 5 nM. Scans were acquired every minute
for 2 hours, and then every 15 minutes for the remainder
of the experiments.
For statistical analysis, within each experiment, CI of
each curve was normalized at the point of treatment.
The slope for each curve of the normalized CI for the
time period between treatment point and the highest CI
value, i.e. confluency, of the untreated cells was calculated.
The calculated slopes were exported and a t-test was
conducted using STATISTICA version 10 (StatSoft, Inc.)
to investigate if the differences between treated and
untreated slopes were significant. Differences were consid-
ered statistically significant if p < 0.05.
Uptake
BEAS 2B, HEK 293, and CHO cells were seeded at 3 ×
104 cells/cm2, 7.6 × 104 cells/cm2, and 1.6 × 104 cells/
cm2, respectively, in 8-well Millicell EZ-slides (Millipore,
Ireland). Cells were allowed to proliferate for 24 hours
prior to treatment at 1 nM for 1, 4, or 6 hours. Following
treatment, cells were washed three times with relevant
culture medium, followed by three washes with Dulbecco’s
Phosphate Buffered Saline (DPBS). Cells were fixed at 4°C
with 4% formalin in Tris/HCl buffer for 15 mins. Slides
were washed once with DPBS and air-dried. Coverslips
were immobilised onto the slides with Kaiser’s gelatine.
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using the CytoViva 150 Unit integrated onto the Olympus
BX43 microscope. Images were acquired using a Dagexcel
X16 camera and the associated software. Hyperspectral
Imaging (HSI) was performed at 60x magnification using
the HSI System 1.1 and ENVI software. In addition to
the scans of the cells treated with gold nanoparticles as
described, scans were also performed on the AuNPs
alone. For this analysis, a drop of AuNP solution was
placed on a microscope slide, spread out and allowed
to dry. A coverslip was placed on the slide prior to the
acquisition of an HSI scan at 60x magnification. Spectral
libraries were collected by selecting the spectra of particles
that appear to either be singularly dispersed or had visually
aggregated to form larger particles. The image classifi-
cation algorithm SAM (spectral angle mapper) was
conducted using the ENVI software to map the spectral
libraries onto the scans of the cells incubated with par-
ticles. A threshold of 0.08 maximum acceptable angles
(radians) between the known and unknown spectra was
applied. In addition, these spectral libraries were visually
compared to those of the AuNPs found within the cells.
Principal Component Analysis (PCA) was performed
(see Additional file 1).
Additional file
Additional file 1: Figure S1. Cell index of BEAS-2B cells showing
toxicity of 500 μM hydrogen peroxide and effect of 5 nM 20 nm AuNPs
in medium on cell index. Figure S2. PCA analysis of 14 nm and 20 nm
AuNP spectra. Figure S3. Spectral profiles of 14 nm AuNPs following
cellular uptake. Figure S4. Spectral profiles of 20 nm AuNPs following
cellular uptake. Table S1. Average hydrodynamic size of 14 nm and 20 nm
AuNPs in culture medium as determined by DLS. Figure S5. Representative
image of the bimodal distribution obtained from DLS.
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